Blood Screening Market Size & Share, 2032 Forecast Report

Blood Screening Market - By Product (Reagents & Kits [NAT, ELISA], Instruments), Technology (Serology/Immunoassays, Rapid Test, Western Blot Assays, NGS), End-use (Hospitals, Blood Banks, Pathology Laboratories) – Global Forecast, 2024-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast calculations

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data Sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global blood screening market 3600&nbsp;synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Product trends

2.1.4&nbsp;&nbsp;&nbsp; Technology trends

2.1.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Blood Screening Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing prevalence of infectious diseases

3.2.1.2&nbsp;&nbsp;&nbsp;Advancements in blood screening technology

3.2.1.3&nbsp;&nbsp;&nbsp;Growing blood transfusion procedures

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of advanced technologies

3.2.2.2&nbsp;&nbsp;&nbsp;Limited access to trained professionals

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By technology

3.3.3&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Future market trends

3.6&nbsp;&nbsp;&nbsp; Technological landscape

3.7&nbsp;&nbsp;&nbsp; Pricing analysis

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2023

4.3&nbsp;&nbsp;&nbsp; Company market share analysis, 2023

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2023

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2023

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2023

Chapter 5&nbsp;&nbsp;&nbsp;Blood Screening Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Reagents &amp; kits

5.2.1&nbsp;&nbsp;&nbsp; NAT reagents &amp; kits

5.2.1.1&nbsp;&nbsp;&nbsp;Enzymes &amp; polymerases

5.2.1.2&nbsp;&nbsp;&nbsp;Standards &amp; controls

5.2.1.3&nbsp;&nbsp;&nbsp;Probes &amp; primers

5.2.1.4&nbsp;&nbsp;&nbsp;Buffer, nucleotides, and solutions

5.2.1.5&nbsp;&nbsp;&nbsp;Labelling &amp; detection reagents

5.2.2&nbsp;&nbsp;&nbsp; ELISA

5.2.2.1&nbsp;&nbsp;&nbsp;Immunosorbents

5.2.2.2&nbsp;&nbsp;&nbsp;Controls

5.2.2.3&nbsp;&nbsp;&nbsp;Conjugates

5.2.2.4&nbsp;&nbsp;&nbsp;Substrates

5.2.2.5&nbsp;&nbsp;&nbsp;Sample diluents &amp; wash solutions

5.2.3&nbsp;&nbsp;&nbsp; Other reagents &amp; kits

5.3&nbsp;&nbsp;&nbsp; Instruments

Chapter 6&nbsp;&nbsp;&nbsp;Blood Screening Market Size and Forecast, By Technology, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by technology

6.2&nbsp;&nbsp;&nbsp; Nucleic acid test

6.2.1&nbsp;&nbsp;&nbsp; Transcription-mediated amplification

6.2.2&nbsp;&nbsp;&nbsp; Real-time PCR

6.3&nbsp;&nbsp;&nbsp; Serology/immunoassays

6.3.1&nbsp;&nbsp;&nbsp; Chemiluminescence immunoassay

6.3.2&nbsp;&nbsp;&nbsp; Fluoresecent immunoassays

6.3.3&nbsp;&nbsp;&nbsp; Colorimeter immunoassays/ELISA

6.4&nbsp;&nbsp;&nbsp; Rapid test

6.5&nbsp;&nbsp;&nbsp; Western blot assays

6.6&nbsp;&nbsp;&nbsp; Next generation sequencing

Chapter 7&nbsp;&nbsp;&nbsp;Blood Screening Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Blood banks

7.4&nbsp;&nbsp;&nbsp; Pathology laboratories

Chapter 8&nbsp;&nbsp;&nbsp;Blood Screening Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.2&nbsp;&nbsp;&nbsp; South Africa

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.2&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd.

9.3&nbsp;&nbsp;&nbsp; Grifols, S.A.

9.4&nbsp;&nbsp;&nbsp; Hologic, Inc.

9.5&nbsp;&nbsp;&nbsp; QIAGEN N.V.

9.6&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

9.7&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc.

9.8&nbsp;&nbsp;&nbsp; Siemens Healthineers AG

9.9&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific, Inc.

9.10&nbsp;&nbsp;&nbsp; SOFINA s.a (Biomerieux)

9.11&nbsp;&nbsp;&nbsp; Danaher Corporation

9.12&nbsp;&nbsp;&nbsp; Ortho-Clinical Diagnostics, Inc.

9.13&nbsp;&nbsp;&nbsp; DiaSorin S.p.A. 
&nbsp;

Blood Screening Market

Get a free sample of this report